Results 31 to 40 of about 3,954,320 (257)

Internal Assessment of Isfahan General Medicine Curriculum Based on Basic standards of Ministry of Health and Medical Education: A Model for Evaluation and Analysis of Results [PDF]

مجله ایرانی آموزش در علوم پزشکی, 2011
Introduction: Necessity for promotion of education quality in course of medicine forced the educational authorities including those of Isfahan school of Medicine to take actions towards promotion of education using an accreditation evaluation model in ...
Mostafa Dehghani Poudeh, Behzad Shams, vahid Ashourioun, Atosa Esmaeilee, Ali Asilian, Parveneh Nasri, Marzieh Hosseini   +6 more
doaj  

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier, Brittany Grantham, Camilla Grud Nielsen, Louise Lundgren, Liv Andrés‐Jensen, Kjeld Schmiegelow, Chris Selman, Gareth Ball, Elyse Passmore, David A. Elliott, Rachel Conyers   +10 more
wiley   +1 more source

The Percapita Cost of Training Undergraduate Medical Students in Shiraz School of Medicine 2007 [PDF]

Strides in Development of Medical Education, 2010
Background & Objective : Costbenefit analysis is a scientific method which helps policy makers to select a project among other projects with the same defined goal making sure that the chosen project has the maximum benefit with a fixed cost or the ...
Javad Kojuri, Farhad Lotfi, Mitra Amini, Ali Pilevar, Zohreh Esmaeelzadeh   +4 more
doaj  

Systolic blood pressure levels and mortality in Australian medical inpatients

The Journal of Clinical Hypertension, 2023
The epidemiology of elevations in blood pressure is incompletely characterized, particularly in Australia. Given the lack of evidence regarding the frequency and the optimal management of in‐hospital hypertension, the authors performed a multicenter ...
Jin Nuo Joan Tsang, Stephen Bacchi, Joshua G. Kovoor, Aashray K. Gupta, Brandon Stretton, Samuel Gluck, Toby Gilbert, Yogesh Sharma, Richard Woodman, Arduino A. Mangoni   +9 more
doaj   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar, Karen Thibaudeau, Mary Mathias, Heather McDaniel, Madlen Reschke, Klaus Tenbrock, Joseph M. Parker, Amy Shapiro   +7 more
wiley   +1 more source

Generative AI in Medicine

New England Journal of Medicine
To appear in the Annual Review of Biomedical Data Science, August ...
Yusuke, Kameda, Yutaka, Kaneko, Saki, Takada   +2 more
openaire   +6 more sources

Swedish Medical LLM Benchmark: development and evaluation of a framework for assessing large language models in the Swedish medical domain

Frontiers in Artificial Intelligence
IntroductionWe present the Swedish Medical LLM Benchmark (SMLB), an evaluation framework for assessing large language models (LLMs) in the Swedish medical domain.MethodThe SMLB addresses the lack of language-specific, clinically relevant benchmarks by ...
Birger Moëll, Fabian Farestam, Jonas Beskow   +2 more
doaj   +1 more source

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot, Mathieu Corvaisier, Laurence Spiesser‐Robelet, Mylène Duplan, Isabelle Pellier, Delphine Bourneau‐Martin, Séverine Derbré   +6 more
wiley   +1 more source

Guidelines for Pediatric Radiotherapy Simulation: A Report From the Children's Oncology Group Radiation Oncology Discipline

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei, Stephen Mihalcik, Sujith Baliga, Young Kwok, Dana Casey, Eric Ehler, Christiane Burton, John C. Breneman, Daphne A. Haas‐Kogan, Suzanne L. Wolden, Arnold C. Paulino, Nadia N. Laack, Natia Esiashvili, Sarah Milgrom, Christine Hill‐Kayser, Thomas J. Fitzgerald, John A. Kalapurakal, Chia‐Ho Hua   +17 more
wiley   +1 more source

The Role of “Adult‐Onset” Cancer Predisposition Genes in Pediatric Cancer: A Comprehensive Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Current literature estimates that 10% of pediatric cancers are caused by pathogenic or likely pathogenic (P/LP) germline variants in cancer predisposition genes (CPGs). Variants in CPGs thought to increase cancer risk exclusively during adulthood are referred to as “adult‐onset” CPGs (aoCPGs).
Maria Rozo, Miriam A. Bornhorst, Angela J. Waanders, Sara Zarnegar‐Lumley, Ashwin Lakshman Koppayi, Lucy A. Godley   +5 more
wiley   +1 more source